{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for guanfacine in Related Substance Name (approximate match)
Showing 1 - 5 of 5 results
Status:
US Approved Rx
(1997)
Source:
ANDA074796
(1997)
Source URL:
First approved in 1986
Source:
TENEX by PROMIUS PHARMA
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Etiguanfacine, also known as SSP-1871, is an α2-adrenoreceptor agonist.
Status:
Possibly Marketed Outside US
Source:
Octaplasma by Octapharma Pharmazeutika Produktionsges M B H [Canada]
Source URL:
First approved in 2013
Source:
BLA125416
Source URL:
Class:
MIXTURE
Status:
US Approved Rx
(1997)
Source:
ANDA074796
(1997)
Source URL:
First approved in 1986
Source:
TENEX by PROMIUS PHARMA
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Etiguanfacine, also known as SSP-1871, is an α2-adrenoreceptor agonist.
Status:
US Approved Rx
(1997)
Source:
ANDA074796
(1997)
Source URL:
First approved in 1986
Source:
TENEX by PROMIUS PHARMA
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Etiguanfacine, also known as SSP-1871, is an α2-adrenoreceptor agonist.
